MCID: VRL011
MIFTS: 68

Viral Infectious Disease

Categories: Infectious diseases, Respiratory diseases

Aliases & Classifications for Viral Infectious Disease

Summaries for Viral Infectious Disease

MedlinePlus : 44 Viruses are very tiny germs. They are made of genetic material inside of a protein coating. Viruses cause familiar infectious diseases such as the common cold, flu and warts. They also cause severe illnesses such as HIV/AIDS, smallpox, and Ebola. Viruses are like hijackers. They invade living, normal cells and use those cells to multiply and produce other viruses like themselves. This can kill, damage, or change the cells and make you sick. Different viruses attack certain cells in your body such as your liver, respiratory system, or blood. When you get a virus, you may not always get sick from it. Your immune system may be able to fight it off. For most viral infections, treatments can only help with symptoms while you wait for your immune system to fight off the virus. Antibiotics do not work for viral infections. There are antiviral medicines to treat some viral infections. Vaccines can help prevent you from getting many viral diseases.

MalaCards based summary : Viral Infectious Disease, also known as arbovirus infections, is related to chronic active epstein-barr virus infection and intermediate uveitis, and has symptoms including fever, pruritus and pathological conditions, signs and symptoms. An important gene associated with Viral Infectious Disease is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Entecavir and Hops have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and kidney, and related phenotypes are Strongly decreased CFP-tsO45G cell surface transport and hematopoietic system

Disease Ontology : 12 A disease by infectious agent that results in infection, has material basis in Viruses.

CDC : 3 Powassan

Wikipedia : 77 A viral disease (or viral infection or infectious disease), occurs when an organism''s body is invaded... more...

Related Diseases for Viral Infectious Disease

Diseases related to Viral Infectious Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1530)
# Related Disease Score Top Affiliating Genes
1 chronic active epstein-barr virus infection 34.6 IFNG IL10 IL2
2 intermediate uveitis 32.8 IFNG IL10 IL2 TNF
3 viral hepatitis 32.7 GPT IFNA1 IFNA2 MX1 TNF
4 hepatitis a 32.7 GPT IFNG IL10 MAVS TNF
5 meningitis 32.6 IFNG IL10 TNF
6 bronchiolitis 32.6 IFNG IL10 TNF
7 encephalitis 32.6 CCR5 CXCL10 DDX58 IRF3 ITIH4 TLR3
8 tonsillitis 32.6 IFNG IL2 TNF
9 marburg hemorrhagic fever 32.5 IFNB1 TNF
10 tick-borne encephalitis 32.5 CCR5 CXCL10 IL10 TLR3
11 west nile virus 32.4 CCR5 DDX58 IFIH1 IFNA1 IRF3 TLR3
12 la crosse encephalitis 32.4 DDX58 IFNB1 IRF3
13 hand, foot and mouth disease 32.4 IFNG IL10 TLR3
14 murray valley encephalitis 32.4 IFNA1 IFNB1 IL2
15 hepatitis e 32.4 GPT IFNG TLR3 TNF
16 newcastle disease 32.4 DDX58 IFNA1 IFNB1 IRF3
17 poliomyelitis 32.4 IFNG IL10 TNF
18 chikungunya 32.3 DDX58 MAVS TNF
19 rabies 32.3 CXCL10 IRF3 MX1 TLR3
20 herpangina 32.3 IFNA1 IFNA2 IFNB1 TLR7
21 herpes zoster 32.3 IFNA2 IFNG IL10 IL2
22 smallpox 32.3 IFNG IL2 TNF
23 mumps 32.3 IFNG IL2 TNF
24 tropical spastic paraparesis 32.3 IFNG IL10 IL2
25 japanese encephalitis 32.3 CXCL10 DDX58 IFNB1 TLR3 TNF
26 rubella 32.2 DDX58 IL10 TNF
27 vaccinia 32.2 IFNA1 IFNB1 IL2 IRF3 IRF7
28 hepatitis b 32.2 GPT IFNA1 IFNA2 IFNG TNF
29 omenn syndrome 32.2 IFNG IL10 TNF
30 herpes simplex 32.2 DDX58 IFIH1 IFNA1 IFNB1 IRF3 TLR3
31 hepatitis c 32.2 CXCL10 DDX58 GPT IFNA1 IFNA2 IFNB1
32 aphthous stomatitis 32.1 IL10 IL2 TNF
33 measles 32.1 DDX58 IFIH1 IFNA1 IFNB1 IFNG IL2
34 severe acute respiratory syndrome 32.1 CXCL10 IFNA1 IFNB1 IFNG IRF3 MX1
35 viral encephalitis 32.1 CXCL10 IL10 MX1 TNF
36 human immunodeficiency virus infectious disease 31.9 CCR5 CD4 IFNA1 IFNG IL10 IL2
37 staphylococcal toxic shock syndrome 31.9 IFNG TNF
38 influenza 31.9 DDX58 IFIH1 IFNA1 IFNB1 IFNG IRF3
39 cryoglobulinemia, familial mixed 31.6 IFNA1 IFNA2
40 eczema herpeticum 31.1 IFNG IRF3 IRF7
41 avian influenza 31.0 CXCL10 DDX58 IRF7 TNF
42 noonan syndrome 3 30.9 DDX58 IFNA1 IFNB1 IRF3 MAVS TLR3
43 autoimmune disease 30.9 IFNA1 IFNG IL10 IL2 TNF
44 myasthenia gravis 30.9 IFNG IL10 IL2 TNF
45 visceral leishmaniasis 30.8 IFNG IL10 IL2 TNF
46 graft-versus-host disease 30.8 IFNG IL10 IL2 TNF
47 lymphadenitis 30.8 IFNG IL10 TNF
48 dengue hemorrhagic fever 30.7 IFNG IL10 TLR3 TNF
49 schistosomiasis 30.7 IFNG IL10 IL2 TNF
50 chronic fatigue syndrome 30.7 IL10 IL2 TNF

Graphical network of the top 20 diseases related to Viral Infectious Disease:



Diseases related to Viral Infectious Disease

Symptoms & Phenotypes for Viral Infectious Disease

UMLS symptoms related to Viral Infectious Disease:


fever, pruritus, pathological conditions, signs and symptoms

GenomeRNAi Phenotypes related to Viral Infectious Disease according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Strongly decreased CFP-tsO45G cell surface transport GR00360-A-2 9.1 CCR5 GPT IFIH1 MAVS TLR3 TLR7

MGI Mouse Phenotypes related to Viral Infectious Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.25 CCR5 CD4 CXCL10 DDX58 IFIH1 IFNB1
2 homeostasis/metabolism MP:0005376 10.24 CCR5 CD4 CXCL10 DDX58 IFIH1 IFNB1
3 cellular MP:0005384 10.23 CCR5 CD4 CXCL10 DDX58 IFIH1 IFNG
4 immune system MP:0005387 10.2 CCR5 CD4 CXCL10 DDX58 IFIH1 IFNB1
5 digestive/alimentary MP:0005381 10.03 CCR5 CD4 DDX58 IFNG IL10 IL2
6 mortality/aging MP:0010768 9.97 CCR5 CD4 CXCL10 DDX58 IFIH1 IFNG
7 liver/biliary system MP:0005370 9.86 CCR5 DDX58 IFIH1 IFNG IL10 IL2
8 neoplasm MP:0002006 9.61 CCR5 DDX58 IFNB1 IFNG IL10 IL2
9 no phenotypic analysis MP:0003012 9.1 CD4 IFNB1 IFNG IL10 IL2 TNF

Drugs & Therapeutics for Viral Infectious Disease

Drugs for Viral Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1298)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Entecavir Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 142217-69-4 153941
2 Hops Approved Phase 4,Not Applicable
3
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 134678-17-4 60825
4
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 104987-11-3 6473866 445643 439492
5
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
6 Ethiodized oil Approved, Investigational Phase 4,Phase 2,Not Applicable 8008-53-5
7
Telbivudine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 3424-98-4 159269
8
Isoniazid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 54-85-3 3767
9
Ribavirin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 36791-04-5 37542
10
Pentoxifylline Approved, Investigational Phase 4,Phase 3,Phase 1 6493-05-6 4740
11
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 62-31-7, 51-61-6 681
12
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 198153-51-4 5360545
13
Amantadine Approved Phase 4,Phase 3,Phase 1,Phase 2 768-94-5 2130
14
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53123-88-9 46835353 5284616 6436030
15
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 159351-69-6 70789204 6442177
16
Tenofovir Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147127-20-6 464205
17
Ezetimibe Approved Phase 4,Phase 2,Phase 1 163222-33-1 150311
18
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85721-33-1 2764
19
rituximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
20
Peginterferon alfa-2b Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 215647-85-1, 99210-65-8
21
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 24280-93-1 446541
22
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
23
Tocopherol Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1406-66-2 14986
24
Dolutegravir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1051375-16-6 54726191
25
Ritonavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 155213-67-5 392622
26
Sofosbuvir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1190307-88-0 45375808
27
Ledipasvir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1256388-51-8 67505836
28
Aluminum hydroxide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 21645-51-2
29
Neomycin Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 1404-04-2 8378
30
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1401-55-4
31
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
32
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
33
Nitazoxanide Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 55981-09-4 41684
34
Efavirenz Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 154598-52-4 64139
35
Lopinavir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 192725-17-0 92727
36
Adefovir dipivoxil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 142340-99-6 60871
37
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 657-24-9 14219 4091
38
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
39
Pioglitazone Approved, Investigational Phase 4,Phase 2,Not Applicable 111025-46-8 4829
40
Montelukast Approved Phase 4,Phase 3,Phase 2,Not Applicable 158966-92-8 5281040
41
Emtricitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 143491-57-0 60877
42
Abacavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 136470-78-5 441300 65140
43
Angiotensin II Approved, Investigational Phase 4,Phase 1,Phase 2 11128-99-7, 68521-88-0, 4474-91-3 172198
44
Lercanidipine Approved, Investigational Phase 4 100427-26-7 65866
45
Candesartan cilexetil Approved Phase 4 145040-37-5 2540
46
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
47
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
48
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-45-6 774
49
Ketotifen Approved Phase 4 34580-14-8, 34580-13-7 3827
50
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741

Interventional clinical trials:

(show top 50) (show all 10074)
# Name Status NCT ID Phase Drugs
1 Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma Unknown status NCT01765231 Phase 4 Entecavir prophylaxis;Observation arm
2 Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine Unknown status NCT02514018 Phase 4
3 Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. Unknown status NCT01063608 Phase 4
4 Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma Unknown status NCT00768157 Phase 4 antiviral treatment (lamivudine or entecavir)
5 Hepatitis C in Renal Transplant Recipients Unknown status NCT02108301 Phase 4 tacrolimus-cyclosporine A
6 Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy Unknown status NCT01102335 Phase 4 Telbivudine
7 The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Unknown status NCT01127282 Phase 4 Vitamin (vitamin A 15 mg,C 500 mg, E 400IU);Placebo (digestive tablet)
8 Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) Unknown status NCT01875952 Phase 4 Isoniazid
9 Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients Unknown status NCT02008214 Phase 4 Pentoxifylline;Placebo
10 Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients Unknown status NCT02624349 Phase 4 Quadravalent human papillomavirus vaccine
11 Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus Unknown status NCT00797030 Phase 4 cyclosporine and sodium carboximethycellulose;sodium carboximethycellulose
12 Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) Unknown status NCT00127777 Phase 4 Amantadine sulphate (in addition to standard treatment)
13 Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant Unknown status NCT01289301 Phase 4 mTOR inhibitor (everolimus);cyclosporine or tacrolimus
14 Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT Unknown status NCT01833611 Phase 4 Entecavir;placebo
15 Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection Unknown status NCT02281266 Phase 4 thymalfasin;nucleoside analog (suggest to use entecavir)
16 Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) Unknown status NCT01311674 Phase 4
17 Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Unknown status NCT01594905 Phase 4 Entecavir + Tenofovir (MDR group)
18 Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2) Unknown status NCT02768545 Phase 4 Ezetimibe
19 Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Unknown status NCT01954810 Phase 4
20 Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females Unknown status NCT01031069 Phase 4
21 Ciprofloxacin for Prevention of BK Infection Unknown status NCT01789203 Phase 4 Ciprofloxacin;placebo
22 Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis Unknown status NCT00663182 Phase 4 Entecavir
23 Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy Unknown status NCT01768195 Phase 4 Entecavir prophylaxis
24 Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines Unknown status NCT01119157 Phase 4
25 Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults Unknown status NCT03160118 Phase 4 Seasonal,quadrivalent,influenza vaccine
26 A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) Unknown status NCT01731301 Phase 4 Ribavirin;Peginterferon;Boceprevir
27 Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? Unknown status NCT01101750 Phase 4
28 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
29 TO Compare the Triple Drug Therapy and Dual Therapy . Unknown status NCT02075242 Phase 4 Mycophenolate Mofetil;Tacrolimus
30 Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C Unknown status NCT01649245 Phase 4 Reiferon retard
31 Improved Prevention of Perinatal Hepatitis B Transmission Unknown status NCT01133184 Phase 4
32 Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients Unknown status NCT00526448 Phase 4 ribavirin;ribavirin;Peginterferon alfa-2a;epoetin beta
33 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
34 Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients Unknown status NCT01148576 Phase 4 entecavir;entecavir;essentiale + entecavir;Vitamin E + entecavir
35 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
36 The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial Unknown status NCT02401828 Phase 4 Dolutegravir
37 Atazanavir/r + Lamivudine Dual Therapy Unknown status NCT01599364 Phase 4 Atazanavir, ritonavir, lamivudine
38 Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients Unknown status NCT00823550 Phase 4 Entecavir;Lamivudine
39 High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids Unknown status NCT01239641 Phase 4
40 Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy Unknown status NCT02638233 Phase 4 Sofosbuvir 400mg / Ledipasvir 90 mg (FDC)
41 Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission Unknown status NCT00939068 Phase 4 Telbivudine
42 Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude Unknown status NCT02523547 Phase 4 Cavir;Baraclude
43 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
44 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
45 Protease Inhibitor vs. Raltegravir-based ART and Inflammation in HIV Infection Unknown status NCT02691065 Phase 4 Integrase Inhibitor
46 Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition Unknown status NCT02005302 Phase 4 1,25(OH)2 Vitamin D3;Vitamin D2
47 Twinrix Alternative Schedule Study Unknown status NCT00216229 Phase 4
48 Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population Unknown status NCT01896609 Phase 4 Bon one in Arm 3;Xerovirinc in Arm 2;Ribavirin in Arm 1
49 Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring Unknown status NCT00836212 Phase 4 Reducing dose of Lopinavir;Reducing dose of efavirenz
50 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4

Search NIH Clinical Center for Viral Infectious Disease

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: arbovirus infections

Genetic Tests for Viral Infectious Disease

Anatomical Context for Viral Infectious Disease

MalaCards organs/tissues related to Viral Infectious Disease:

42
Testes, T Cells, Kidney, B Cells, Bone Marrow, Brain, Skin

Publications for Viral Infectious Disease

Articles related to Viral Infectious Disease:

(show top 50) (show all 86)
# Title Authors Year
1
Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the Region of the Americas: Implications for Health Policy. ( 30676796 )
2019
2
Implementation of the One Health approach to fight arbovirus infections in the Mediterranean and Black Sea Region: Assessing integrated surveillance in Serbia, Tunisia and Georgia. ( 30724030 )
2019
3
Is PBC a viral infectious disease? ( 30343707 )
2018
4
Emerging souvenirs-clinical presentation of the returning traveller with imported arbovirus infections in Europe. ( 29339224 )
2018
5
Strengthening Preparedness for Arbovirus Infections in Mediterranean and Black Sea Countries: A Conceptual Framework to Assess Integrated Surveillance in the Context of the One Health Strategy. ( 29534445 )
2018
6
Mapping innate and adaptive immune function in arbovirus infections. ( 29667753 )
2018
7
Risk factors for arbovirus infections in a low-income community of Rio de Janeiro, Brazil, 2015-2016. ( 29879155 )
2018
8
Unexpected outbreaks of arbovirus infections: lessons learned from the Pacific and tropical America. ( 29934112 )
2018
9
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors. ( 30272671 )
2018
10
Lack of serological and molecular evidence of arbovirus infections in bats from Brazil. ( 30403749 )
2018
11
Concurrent malaria and arbovirus infections in Kedougou, southeastern Senegal. ( 26821709 )
2016
12
Documentation of transfusion-transmitted arbovirus infections in endemic areas. ( 27933623 )
2016
13
Arbovirus infections of the nervous system: current trends and future threats. ( 25628429 )
2015
14
Arbovirus Infections. ( 26633778 )
2015
15
National capacity for surveillance, prevention, and control of West Nile virus and other arbovirus infections--United States, 2004 and 2012. ( 24699764 )
2014
16
Mosquito immune responses to arbovirus infections. ( 25401084 )
2014
17
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections. ( 24058915 )
2013
18
Evolutionary analysis of the dynamics of viral infectious disease. ( 19564871 )
2009
19
Viral infectious disease and natural products with antiviral activity. ( 22504360 )
2007
20
Control of arbovirus infections by a coordinated response: West Nile Virus in England and Wales. ( 17054715 )
2006
21
Serologic survey of domestic animals for zoonotic arbovirus infections in the Lacandón Forest region of Chiapas, Mexico. ( 12804375 )
2003
22
Human arbovirus infections worldwide. ( 11797771 )
2001
23
Arbovirus infections of ruminants in al-Rub al-Khali desert. ( 9533283 )
1998
24
The dispersal of Culicoides brevitarsis in eastern New South Wales and associations with the occurrences of arbovirus infections in cattle. ( 8660239 )
1996
25
IL12 in acute viral infectious disease. ( 8839166 )
1995
26
Surveillance of arbovirus infections in the Atlantic Forest Region, State of São Paulo, Brazil. I. Detection of hemagglutination-inhibiting antibodies in wild birds between 1978 and 1990. ( 7855491 )
1994
27
Arbovirus infections of humans in high-risk areas of south-eastern Australia: a continuing study. ( 8393128 )
1993
28
Imported arbovirus infections in Canada 1974-89. ( 22529717 )
1991
29
Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984. ( 2559514 )
1989
30
Postinfection therapy of arbovirus infections in mice. ( 2619276 )
1989
31
Arbovirus infections in several Ontario mammals, 1975-1980. ( 3017527 )
1986
32
Post-encephalitic epilepsy and arbovirus infections in an isolated rainforest area of central Liberia. ( 3018970 )
1986
33
Human arbovirus infections along the south coast of New South Wales. ( 3767767 )
1986
34
Arbovirus infections of humans in New South Wales. Seroepidemiology of the flavivirus group of togaviruses. ( 3007952 )
1985
35
Prevalence of hepatitis virus and some arbovirus infections in Kavango, northern SWA/Namibia. ( 3983734 )
1985
36
Arbovirus infections in humans in New South Wales. Seroepidemiology of the alphavirus group of togaviruses. ( 6094993 )
1984
37
Sequelae to arbovirus infections in former Far East prisoners-of-war. ( 6144958 )
1984
38
Serologic evidence of arbovirus infections in humans and wild animals in Alaska. ( 6644915 )
1983
39
Early diagnosis of viraemia in some experimental arbovirus infections in mice. ( 6118053 )
1981
40
Arbovirus infections among laboratory personnel in Ibadan, Nigeria. ( 7196163 )
1981
41
A multidisciplinary program of infectious disease surveillance along the Transamazon highway in Brazil: epidemiology of arbovirus infections. ( 7248635 )
1981
42
Serological survey for human arbovirus infections in the province of Quebec. ( 6256047 )
1980
43
Epidemiological investigations on arbovirus infections at Igbo-Ora, Nigeria. ( 906078 )
1977
44
Arbovirus infections in Sarawak: the role of the domestic pig. ( 1265821 )
1976
45
Arbovirus infections in reptiles: studies on the presence of Japanese encephalitis virus antibody in the plasma of the turtle, Trionyx sinensis. ( 170690 )
1975
46
The significance of mosquito longevity and blood-feeding behaviour in the dynamics of arbovirus infections. ( 1604 )
1975
47
Arbovirus infections in Sarawak, October 1968--February 1970 Tembusu and Sindbis virus isolations from mosquitoes. ( 235907 )
1975
48
Arbovirus infections in Sarawak, October 1968-February 1970: GETAH virus isolations from mosquitoes. ( 238314 )
1975
49
Arbovirus infections in Sarawak, October 1968-February 1970: human serological studies in a land Dyak village. ( 809868 )
1975
50
Arbovirus infections in Sarawak, October 1968--February 1970: Japanese encephalitis virus isolations from mosquitoes. ( 4155608 )
1974

Variations for Viral Infectious Disease

Expression for Viral Infectious Disease

Search GEO for disease gene expression data for Viral Infectious Disease.

Pathways for Viral Infectious Disease

Pathways related to Viral Infectious Disease according to GeneCards Suite gene sharing:

(show top 50) (show all 59)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.03 CCR5 CD4 CXCL10 DDX58 IFIH1 IFNA1
2
Show member pathways
13.7 CCR5 CD4 CXCL10 IFNA1 IFNA2 IFNB1
3
Show member pathways
13.56 CD4 IFNA1 IFNA2 IFNB1 IFNG IL10
4
Show member pathways
13.43 CCR5 CD4 CXCL10 IL10 IL2 TLR3
5
Show member pathways
13.34 IFNA1 IFNA2 IFNB1 IL2 IRF3 IRF7
6
Show member pathways
13.28 CCR5 CD4 CXCL10 DDX58 IFNA1 IFNA2
7
Show member pathways
13.04 IFNA1 IFNA2 IFNB1 IL2 IRF3 MX1
8
Show member pathways
13.01 CCR5 CD4 DDX58 IFIH1 IFNA1 IFNA2
9
Show member pathways
12.93 CD4 IFNA1 IFNA2 IFNG IL10 IL2
10
Show member pathways
12.9 CXCL10 IFNA1 IFNA2 IFNB1 IFNG IL10
11
Show member pathways
12.65 CD4 IFNG IL10 IL2 TNF
12
Show member pathways
12.64 IRF3 IRF7 TLR3 TLR7 TNF
13
Show member pathways
12.63 CCR5 CD4 IFNG IL10 IL2 TNF
14
Show member pathways
12.62 CD4 IFNG IL10 IL2 TNF
15
Show member pathways
12.62 DDX58 IFNA1 IFNA2 IFNB1 IFNG IRF3
16
Show member pathways
12.61 CD4 IFNG IL10 IL2 TNF
17
Show member pathways
12.59 IFNA1 IFNA2 IFNB1 IFNG IL2 TNF
18
Show member pathways
12.51 DDX58 IFIH1 IRF3 IRF7 MAVS TLR3
19
Show member pathways
12.46 CCR5 IFNA1 IFNA2 IFNB1 IFNG IL10
20
Show member pathways
12.4 CXCL10 DDX58 IFIH1 IFNA1 IFNA2 IFNB1
21
Show member pathways
12.35 IFNB1 IRF3 IRF7 TLR3 TLR7 TNF
22
Show member pathways
12.32 IFNG IRF3 TLR3 TNF
23
Show member pathways
12.32 IFNA1 IFNA2 IFNB1 IFNG
24 12.31